hims & hers fda warning letter compounded semaglutide 2025 issued 25 letters to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of 🚨 FDA Moves to Permanently

Hunger that feels biological, not motivational

If survodutide reaches market before retatrutide, it could provide early real-world evidence on glucagon receptor safety, which would benefit the retatrutide review process

Retatrutide, also known as "Reta," is a next-generation GLP-1 medication being developed by Eli Lilly to treat obesity

Health care professionals may prescribe GLP-1s for people with diabetes and binge eating disorder with strong psychotherapy support, a slow dose titration and close follow-up after initiation, according to two speakers

Use of topical treatments like minoxidil to stimulate hair regrowth

In the United States, the 988 Suicide & Crisis Lifeline is available 24/7 by call or text